Scientists have uncovered a promising new electrical brain signal that could forecast Alzheimer’s disease progression years ahead of clinical diagnosis, providing a direct window into neuronal health. The discovery, from Brown University’s Carney Institute for Brain Science, focuses on transient “beta events” bursts of 12–30 Hz oscillations critical for memory and cognition.

In patients with mild cognitive impairment (MCI), those who progressed to Alzheimer’s within ~2.5 years exhibited significantly weaker beta events: lower occurrence rate, shorter duration, and reduced power compared to non-progressors. This pattern reflects early synaptic dysfunction from toxic proteins, appearing before overt symptoms.

The breakthrough relies on the Spectral Events Toolbox, an open-source analytical method to quantify these fleeting signals in MEG data. Unlike amyloid/tau biomarkers (detecting pathology presence), this measures functional impact how neurons communicate amid toxicity.

Lead researcher Stephanie Jones, professor of neuroscience, stated: “We’ve detected a pattern. that predicts which patients are most likely to develop the disease within two and a half years.”

Next steps include replicating findings, modeling mechanisms, and testing therapeutics to restore beta events. If validated, routine MEG scans could flag at-risk individuals early, monitor interventions, and enrich clinical trials.

This functional biomarker advances noninvasive early detection, complementing blood/spinal fluid tests for a fuller pre-symptomatic picture.